Both in Biotechnology
Aligos Therapeutics vs Pelthos Therapeutics
Over the past year ALGS returned −32.7% and PTHS returned −70.4%; their daily moves had a correlation of 0.12.
ALGS −32.7% PTHS −70.4%Growth of $1, one year, split-adjusted
| Metric | ALGS | PTHS |
|---|---|---|
| Price | $4.75 | $10.78 |
| Market cap | $29.7M | $42.4M |
| Today | +3.26% | −6.42% |
| 1 month | −12.0% | −47.4% |
| 6 months | −25.2% | −57.6% |
| Year to date | −49.0% | −65.2% |
| 1 year | −42.4% | — |
| Revenue growth (YoY) | +2778.5% | — |
| Gross margin | 100.0% | 76.9% |
| Net margin | −5.4% | −150.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 1.0× |
| Net cash | $30.3M | -$45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 65.0% | 140.4% |
| Short % of float | 12.7% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).